Literature DB >> 6796769

Studies on human phenylalanine Mono-oxygenase. I. Restricted expression.

M D Crawfurd, D A Gibbs, D M Sheppard.   

Abstract

Enzyme assays for phenylalanine mono-oxygenase have been performed on a variety of non-hepatic human cell types under varying conditions. The cell types studied were cultured fibroblasts, short-term lymphocyte cultures, long-term lymphoblastoid cultures, cultured amniotic fluid cells, hair roots and placental extracts. The cultured cells were assayed after growth under standard conditions and in the presence of a high concentration of substrate, a low concentration of end-product, added hydrocortisone or dexamethasone and under combinations of these conditions. In no instance was a significant enzyme activity obtained.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796769     DOI: 10.1007/BF02263650

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Phenylalanine hydroxylase activity in liver from humans and subhuman primates: its probable absence in kidney.

Authors:  L I Murthy; H K Berry
Journal:  Biochem Med       Date:  1975-04

2.  A direct assay for liver phenylalanine hydroxylase.

Authors:  C Bublitz
Journal:  Biochim Biophys Acta       Date:  1969-11-04

3.  Avoiding artifactual errors in assay of phenylalanine hydroxylase.

Authors:  M C Hsieh; H K Berry
Journal:  Clin Chem       Date:  1979-02       Impact factor: 8.327

4.  Immunological detection of phenylalanine hydroxylase in phenylketonuria.

Authors:  K Bartholomé; E Ertel
Journal:  Lancet       Date:  1976-10-16       Impact factor: 79.321

5.  Phenylalanine hydroxylase in human placenta: novel system for study of phenylketonuria.

Authors:  R Matalon; P Justice; M N Deanching
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

6.  Phenylalanine hydroxylase activity in fibroblasts.

Authors:  V Cassano; R S Krooth; T E Worthy
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

7.  Phenylalanine has no effect on dihydropteridine reductase activity in phenylketonuria fibroblasts.

Authors:  F Guttler; S Kaufman; S Milstien
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

8.  Phenylalanine hydroxylation in cultured fibroblasts from patients with phenylketonuria.

Authors:  R W Hoffbauer; G Schrempf
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

9.  Adaptation of hepatic phenylalanine hydroxylase in the rat.

Authors:  C Koller; R Klinger; G Anderson
Journal:  Enzyme       Date:  1974

10.  Phenylalanine hydroxylation and tyrosine requirement of cultured cells. Evidence of phenylalanine hydroxylation in mastocytoma cells in culture.

Authors:  K H Choo; R G Cotton; D M Danks
Journal:  Exp Cell Res       Date:  1976-09       Impact factor: 3.905

View more
  3 in total

Review 1.  Somatic gene therapy for phenylketonuria and other hepatic deficiencies.

Authors:  R C Eisensmith; S L Woo
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 2.  Severe mental handicap: pathogenesis, treatment, and prevention.

Authors:  M D Crawfurd
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-18

3.  Retroviral-mediated gene transfer and expression of human phenylalanine hydroxylase in primary mouse hepatocytes.

Authors:  H Peng; D Armentano; L MacKenzie-Graham; R F Shen; G Darlington; F D Ledley; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.